Icon

DOPTELET (nda210238)- (EQ 20MG BASE)

AVATROMBOPAG MALEATE AKARX INC
EQ 20MG BASE
No No
2027-Jul-28 2023-May-21
None None
None No
DOPTELET is a thrombopoietin receptor agonist indicated for the treatment of: • Thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. • Thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.
0 0 0
Total Other Developers 9
Drugs with Suitability No
EQ 20MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.